Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus

Standard

Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus. / Markus, Marcello Ricardo Paulista; Ittermann, Till; Schipf, Sabine; Bahls, Martin; Nauck, Matthias; Völzke, Henry; Santos, Raul Dias; Peters, Annette; Zeller, Tanja; Felix, Stephan Burkhard; Vasan, Ramachandran S; Thorand, Barbara; Steinhagen-Thiessen, Elisabeth; Dörr, Marcus.

In: CARDIOVASC DIABETOL, Vol. 20, No. 1, 168, 18.08.2021.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Markus, MRP, Ittermann, T, Schipf, S, Bahls, M, Nauck, M, Völzke, H, Santos, RD, Peters, A, Zeller, T, Felix, SB, Vasan, RS, Thorand, B, Steinhagen-Thiessen, E & Dörr, M 2021, 'Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus', CARDIOVASC DIABETOL, vol. 20, no. 1, 168. https://doi.org/10.1186/s12933-021-01363-x

APA

Markus, M. R. P., Ittermann, T., Schipf, S., Bahls, M., Nauck, M., Völzke, H., Santos, R. D., Peters, A., Zeller, T., Felix, S. B., Vasan, R. S., Thorand, B., Steinhagen-Thiessen, E., & Dörr, M. (2021). Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus. CARDIOVASC DIABETOL, 20(1), [168]. https://doi.org/10.1186/s12933-021-01363-x

Vancouver

Bibtex

@article{cd1555f3836c4e3ba6f28d9ee58b05cb,
title = "Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus",
abstract = "BACKGROUND: Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men in individuals with type 2 diabetes mellitus.METHODS: We evaluated data from 7443 individuals (3792 women, 50.9%), aged 20 to 81 years, from two independent population-based investigations, SHIP-0 and MONICA/KORA S3. We analyzed the longitudinal sex-specific associations of lipoprotein(a) with cardiovascular mortality in individuals with and without type 2 diabetes mellitus using Cox regression.RESULTS: During a median follow-up of 20.5 years (136,802 person-years), 657 participants (404 men and 253 women) died of cardiovascular causes. Among individuals without type 2 diabetes mellitus, men had a significantly higher risk for cardiovascular mortality compared to women in unadjusted model and after adjustment. On the other hand, in participants with type 2 diabetes mellitus, the risk for cardiovascular mortality was not different between men and women in the unadjusted model and after adjustment for age, body mass index, low-density lipoprotein-cholesterol, fasting status and study sample (SHIP-0, MONICA/KORA S3). Further adjustment for lipoprotein(a) concentrations had no impact on the hazard ratio (HR) for cardiovascular mortality comparing men versus women in individuals without type 2 diabetes mellitus [HR: 1.94; 95% confidence interval (CI) 1.63 to 2.32; p < 0.001]. In individuals with type 2 diabetes mellitus, however, further adjustment for lipoprotein(a) led to an increased risk for cardiovascular mortality in men and a decreased risk in women resulting in a statistically significant difference between men and women (HR: 1.53; 95% CI 1.04 to 2.24; p = 0.029).CONCLUSIONS: Women are described to have a stronger relative increase in cardiovascular mortality than men when comparing individuals with and without type 2 diabetes mellitus. Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus than in men with type 2 diabetes mellitus might partially explain this finding.",
keywords = "Adult, Aged, Aged, 80 and over, Biomarkers/blood, Cardiovascular Diseases/blood, Diabetes Mellitus, Type 2/blood, Female, Germany/epidemiology, Health Status Disparities, Humans, Incidence, Lipoprotein(a)/blood, Longitudinal Studies, Male, Middle Aged, Prevalence, Prognosis, Risk Assessment, Risk Factors, Sex Factors, Time Factors, Young Adult",
author = "Markus, {Marcello Ricardo Paulista} and Till Ittermann and Sabine Schipf and Martin Bahls and Matthias Nauck and Henry V{\"o}lzke and Santos, {Raul Dias} and Annette Peters and Tanja Zeller and Felix, {Stephan Burkhard} and Vasan, {Ramachandran S} and Barbara Thorand and Elisabeth Steinhagen-Thiessen and Marcus D{\"o}rr",
note = "{\textcopyright} 2021. The Author(s).",
year = "2021",
month = aug,
day = "18",
doi = "10.1186/s12933-021-01363-x",
language = "English",
volume = "20",
journal = "CARDIOVASC DIABETOL",
issn = "1475-2840",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus

AU - Markus, Marcello Ricardo Paulista

AU - Ittermann, Till

AU - Schipf, Sabine

AU - Bahls, Martin

AU - Nauck, Matthias

AU - Völzke, Henry

AU - Santos, Raul Dias

AU - Peters, Annette

AU - Zeller, Tanja

AU - Felix, Stephan Burkhard

AU - Vasan, Ramachandran S

AU - Thorand, Barbara

AU - Steinhagen-Thiessen, Elisabeth

AU - Dörr, Marcus

N1 - © 2021. The Author(s).

PY - 2021/8/18

Y1 - 2021/8/18

N2 - BACKGROUND: Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men in individuals with type 2 diabetes mellitus.METHODS: We evaluated data from 7443 individuals (3792 women, 50.9%), aged 20 to 81 years, from two independent population-based investigations, SHIP-0 and MONICA/KORA S3. We analyzed the longitudinal sex-specific associations of lipoprotein(a) with cardiovascular mortality in individuals with and without type 2 diabetes mellitus using Cox regression.RESULTS: During a median follow-up of 20.5 years (136,802 person-years), 657 participants (404 men and 253 women) died of cardiovascular causes. Among individuals without type 2 diabetes mellitus, men had a significantly higher risk for cardiovascular mortality compared to women in unadjusted model and after adjustment. On the other hand, in participants with type 2 diabetes mellitus, the risk for cardiovascular mortality was not different between men and women in the unadjusted model and after adjustment for age, body mass index, low-density lipoprotein-cholesterol, fasting status and study sample (SHIP-0, MONICA/KORA S3). Further adjustment for lipoprotein(a) concentrations had no impact on the hazard ratio (HR) for cardiovascular mortality comparing men versus women in individuals without type 2 diabetes mellitus [HR: 1.94; 95% confidence interval (CI) 1.63 to 2.32; p < 0.001]. In individuals with type 2 diabetes mellitus, however, further adjustment for lipoprotein(a) led to an increased risk for cardiovascular mortality in men and a decreased risk in women resulting in a statistically significant difference between men and women (HR: 1.53; 95% CI 1.04 to 2.24; p = 0.029).CONCLUSIONS: Women are described to have a stronger relative increase in cardiovascular mortality than men when comparing individuals with and without type 2 diabetes mellitus. Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus than in men with type 2 diabetes mellitus might partially explain this finding.

AB - BACKGROUND: Compared to individuals without type 2 diabetes mellitus, the relative increase in cardiovascular mortality is much higher in women than in men in individuals with type 2 diabetes mellitus.METHODS: We evaluated data from 7443 individuals (3792 women, 50.9%), aged 20 to 81 years, from two independent population-based investigations, SHIP-0 and MONICA/KORA S3. We analyzed the longitudinal sex-specific associations of lipoprotein(a) with cardiovascular mortality in individuals with and without type 2 diabetes mellitus using Cox regression.RESULTS: During a median follow-up of 20.5 years (136,802 person-years), 657 participants (404 men and 253 women) died of cardiovascular causes. Among individuals without type 2 diabetes mellitus, men had a significantly higher risk for cardiovascular mortality compared to women in unadjusted model and after adjustment. On the other hand, in participants with type 2 diabetes mellitus, the risk for cardiovascular mortality was not different between men and women in the unadjusted model and after adjustment for age, body mass index, low-density lipoprotein-cholesterol, fasting status and study sample (SHIP-0, MONICA/KORA S3). Further adjustment for lipoprotein(a) concentrations had no impact on the hazard ratio (HR) for cardiovascular mortality comparing men versus women in individuals without type 2 diabetes mellitus [HR: 1.94; 95% confidence interval (CI) 1.63 to 2.32; p < 0.001]. In individuals with type 2 diabetes mellitus, however, further adjustment for lipoprotein(a) led to an increased risk for cardiovascular mortality in men and a decreased risk in women resulting in a statistically significant difference between men and women (HR: 1.53; 95% CI 1.04 to 2.24; p = 0.029).CONCLUSIONS: Women are described to have a stronger relative increase in cardiovascular mortality than men when comparing individuals with and without type 2 diabetes mellitus. Higher lipoprotein(a) concentrations in women with type 2 diabetes mellitus than in men with type 2 diabetes mellitus might partially explain this finding.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biomarkers/blood

KW - Cardiovascular Diseases/blood

KW - Diabetes Mellitus, Type 2/blood

KW - Female

KW - Germany/epidemiology

KW - Health Status Disparities

KW - Humans

KW - Incidence

KW - Lipoprotein(a)/blood

KW - Longitudinal Studies

KW - Male

KW - Middle Aged

KW - Prevalence

KW - Prognosis

KW - Risk Assessment

KW - Risk Factors

KW - Sex Factors

KW - Time Factors

KW - Young Adult

U2 - 10.1186/s12933-021-01363-x

DO - 10.1186/s12933-021-01363-x

M3 - SCORING: Journal article

C2 - 34407812

VL - 20

JO - CARDIOVASC DIABETOL

JF - CARDIOVASC DIABETOL

SN - 1475-2840

IS - 1

M1 - 168

ER -